ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
90 hedge funds and large institutions have $47.5M invested in Endocyte, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 25 increasing their positions, 31 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Holders
90
Holding in Top 10
–
Calls
$353K
Puts
$54K
Top Buyers
| 1 | +$584K | |
| 2 | +$540K | |
| 3 | +$485K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$423K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$337K |
Top Sellers
| 1 | -$808K | |
| 2 | -$475K | |
| 3 | -$188K | |
| 4 |
EGA
Eagle Global Advisors
Houston,
Texas
|
-$167K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$139K |